Lifestyle Intervention in Patients With Metastatic Prostate Cancer

Critères d'exclusion

• Ongoing treatment with docetaxel, cabazitaxel, radionuclides or investigational treatments • Evidence of clinical progression or progression of disease on imaging • Bone metastases excluding the safety of physical exercise • Prior confirmed severe osteoporosis or other diseases affecting the bone with history of fractures • Clinically significant cardiovascular disease (i.e. myocardial infarction within 6 months before screening; uncontrolled angina within 3 months before screening; congestive heart failure New York Heart Association class 3 or 4; history of clinically significant arrhythmias; uncontrolled hypertension indicated by systolic blood pressure \> 170 mm Hg or diastolic blood pressure \> 105 mm Hg at screening) • Clinically significant chronic obstructive pulmonary disease • Any concurrent disease or comorbid condition that interferes with the ability of the patient to participate in the study